A detailed history of Rosenberg Matthew Hamilton transactions in Abb Vie Inc. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 2,987 shares of ABBV stock, worth $608,003. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,987
Previous 2,950 1.25%
Holding current value
$608,003
Previous $505,000 16.63%
% of portfolio
0.16%
Previous 0.15%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $6,062 - $7,375
37 Added 1.25%
2,987 $589,000
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $70,429 - $82,245
-455 Reduced 13.36%
2,950 $505,000
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $4,794 - $5,463
30 Added 0.89%
3,405 $620,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $11,145 - $12,552
81 Added 2.46%
3,375 $523,000
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $11,755 - $13,609
-88 Reduced 2.6%
3,294 $491,000
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $99,249 - $123,510
-749 Reduced 18.13%
3,382 $455,000
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $13,304 - $15,321
-92 Reduced 2.18%
4,131 $658,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $13,831 - $16,587
100 Added 2.43%
4,223 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $32,210 - $36,943
240 Added 6.18%
4,123 $553,000
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $41,423 - $52,662
301 Added 8.4%
3,883 $597,000
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $34,446 - $42,738
261 Added 7.86%
3,582 $581,000
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $26,857 - $33,982
250 Added 8.14%
3,321 $450,000
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $83,736 - $95,053
787 Added 34.46%
3,071 $331,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $7,485 - $10,106
-93 Reduced 3.91%
2,284 $245,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $40,133 - $53,704
547 Added 29.89%
2,377 $233,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $118,035 - $178,955
1,830 New
1,830 $140,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.